| Record ID | marc_columbia/Columbia-extract-20221130-024.mrc:75621709:2003 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-024.mrc:75621709:2003?format=raw |
LEADER: 02003cam a2200481Ki 4500
001 11628285
005 20160123212916.0
008 150313t20142014mx 000 0 spa d
020 $a9786077775485
020 $a6077775487
035 $a(OCoLC)ocn898588737
035 $a(OCoLC)898588737
035 $a(NNC)11628285
040 $aAZU$beng$cAZU$dOCLCO$dAZU$dCUS$dOCLCF
043 $an-mx---
050 $aRM302.5$b.H37 2014
245 00 $aFarmacovigilancia en México :$bprevención precaria y consumo de medicamentos /$cJesús Armando Haro Encinas, Rubén Calderón Ortiz, Álex Covarrubias Valdenebro, Jesús Gerardo Mada Vélez, Paul Hersch Martínez, Juan Enrique Ramos Salas.
264 1 $aHermosillo, Sonora, México :$bEl Colegio de Sonora,$c[2014]
264 4 $c©2014
300 $a293 pages :$c23 cm.
650 0 $aDrugs$zMexico$xSafety measures.
650 0 $aDrugs$xSide effects$zMexico.
650 0 $aHealth risk assessment$zMexico.
650 0 $aPharmacoepidemiology$zMexico.
650 4 $aDrogas$xMedidas de seguridad.
650 4 $aDrogas$xEfectos secundarios.
650 4 $aEvaluación de riesgos contra la salud.
650 4 $aFarmacoepidemiologIa.
650 2 $aDrug-Related Side Effects and Adverse Reactions.
651 2 $aMexico.
650 2 $aPharmaceutical Preparations$xstandards.
650 7 $aDrugs$xSafety measures.$2fast$0(OCoLC)fst00898909
650 7 $aDrugs$xSide effects.$2fast$0(OCoLC)fst00898912
650 7 $aHealth risk assessment.$2fast$0(OCoLC)fst00953250
650 7 $aPharmacoepidemiology.$2fast$0(OCoLC)fst01060242
651 7 $aMexico.$2fast$0(OCoLC)fst01211700
700 1 $aHaro E., J. Armando$q(Jesús Armando),$eauthor.
700 1 $aRamos Salas, Juan Enrique,$eauthor.
700 1 $aHersch Martínez, Paul,$d1955-$eauthor.
700 1 $aMada Vélez, Jesús Gerardo,$eauthor.
700 1 $aCovarrubias V., Alejandro,$eauthor.
700 1 $aCalderón Ortiz, Rubén,$eauthor.
852 00 $bglx$hRM302.5$i.H37 2014